3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Multiple Myeloma
8
Lymphoma, Non-Hodgkin
7
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms, Plasma Cell
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hodgkin Disease
3
Glioma
3
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Melanoma
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Glioblastoma
2
Wilms Tumor
1
Solid Tumor
1
Sarcoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Fallopian Tube Neoplasms
1
Interventions
Fluorodeoxyglucose F18
7
Irinotecan
4
Fluorouracil
4
Cyclophosphamide
4
Bevacizumab
4
toripalimab
3
pembrolizumab
3
olaparib
3
Radiosurgery
3
Cisplatin
3
Capecitabine
3
vistusertib
2
tislelizumab
2
spartalizumab
2
fludarabine
2
atezolizumab
2
apatinib
2
Temozolomide
2
Technetium
2
Specimen Handling
2
Sirolimus
2
Radiotherapy
2
Proton Therapy
2
Paclitaxel
2
Leucovorin
2
Letrozole
2
Hydroxychloroquine
2
Everolimus
2
Drug Therapy
2
Docetaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solid Tumor
×
Blood Component Removal
×
Clear all
NCT07137312
2025-12-23
Ex Vivo Expansion (ACT-X)
Mayo Clinic
Recruiting
24 enrolled